Acquisition of Software for Whole-Genome Sequencing
Location:
United States
Posted on:
Deadline:
Summary:
NIH seeks to renew a Sentieon software license to support rapid, accurate whole-genome sequencing for cancer research.
Get full access to this RFP
Download the full RFP document and use Settle's AI to analyze requirements, estimate budget, and draft winning responses in minutes.
The National Institutes of Health (NIH), National Cancer Institute (NCI), Integrative Tumor Epidemiology Branch (ITEB) seeks to procure the annual renewal of one Sentieon software license for whole-genome sequencing. This license renewal is essential for facilitating high-speed, accurate variant detection within large tumor cohorts, a critical component of ongoing cancer genomics research.
The Sentieon software provides a 20–50 fold increase in processing speed compared to existing solutions, without compromising accuracy. Its proprietary nature and performance characteristics enable ITEB to accelerate research workflows while efficiently managing computational resources. The renewal will ensure continued support for planned projects and maintain cost efficiency for the federal government. Interested parties able to meet these requirements may submit capability statements for consideration, with responses due by 2:00 PM EST, March 2, 2026.
